OnKure Therapeutics, Inc. (OKUR) Operating cash flow 2020–2025
OnKure Therapeutics, Inc. (OKUR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$51.8MFY2025 · since FY2020: -$18.5M → -$51.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$51.8M | -1.4% |
| FY2024 | -$51.1M | -48.0% |
| FY2023 | -$34.5M | +27.1% |
| FY2022 | -$47.4M | -24.7% |
| FY2021 | -$38.0M | -104.9% |
| FY2020 | -$18.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice